SOAT1 and myeloproliferative neoplasm: RAS mutations were either present within the MPN driver clone, or in a clone without a driver mutation, suggesting that ruxolitinib-induced RAS clonal selection can occur both in a JAK/STAT hyper-activated or WT context (Fig. 3B).